lucia torracca
DESCRIPTION
Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING ON FEMALE DISEASES Milano 9 - 10 aprile 2010. Lucia Torracca. Il bypass aorto-coronarico : più rischioso e meno efficace ?. L. Torracca. Direttore U.O. Cardiochirurgia - PowerPoint PPT PresentationTRANSCRIPT
Lucia Torracca
Tenth International Symposium
HEART FAILURE & Co.CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING
ON FEMALE DISEASES
Milano9 - 10 aprile 2010
Il bypass aorto-coronarico:Il bypass aorto-coronarico:
più rischioso e meno efficace? più rischioso e meno efficace?
Direttore U.O. CardiochirurgiaDirettore U.O. Cardiochirurgia
A.O.U. Ospedali Riuniti “Umberto I- G. M. Lancisi- G. Salesi”A.O.U. Ospedali Riuniti “Umberto I- G. M. Lancisi- G. Salesi”
Presidio Monospecialistico “G. M. Lancisi”Presidio Monospecialistico “G. M. Lancisi”
AnconaAncona
L. TorraccaL. Torracca
Preoperative risk profile(women versus men)
• Older
• Diabetes/Obesity/Hypertension
• Smaller body surface area
• Lower hematocrit
• Congestive heart failure/NYHA class IV
• IV heparin/nitroglycerin
• Urgent/emergent operation
• Higher STS estimated mortality
Aldea Ann Thorac Surg 1999Single center consecutive 1743 pts
Operative risk factorsOperative risk factors
Internal mammary artery useInternal mammary artery use
FEMALE vs MALE
64% vs 78% O’Connor 1993
65% vs 76% Edwards 1998
67% vs 80% Humphries 2007
83% vs 89% Bukkapatnam 2010
- 2 groups of patients 261 women and 261 men “computer-matched”
- All pts bilateral IMA graft
- Hospital mortality 3,4% vs 3,8% (women vs men)
Female and leg wound complicationsFemale and leg wound complications
Paletta Ann Thorac Surg 2000;70:492
• Increase the use of “at least” one or “better” two mammary arteries
• Optimal management of blood glucose level (100-150mg/dl)
• Intraop management of anemia (nadir Ht>22 during CPB): reduce pump prime, ultrafiltration